The S&P 500 rallied in the wake of last week's election results, climbing 3.8% since Nov. 5 at Wednesday's prices. But not ...

The Invesco Biotechnology & Genome ETF (PBE) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

SPDR® S&P Biotech ETF is a well-diversified, low-cost ETF that can be an excellent tool to capitalize on the potential of the biotech stock sector. XBI's performance should be compared with the ...

A smart beta exchange traded fund, the SPDR S&P Biotech ETF (XBI) debuted on 01/31/2006, and offers broad exposure to the Health Care ETFs category of the market. Products that are based on market ...

Avidian Wealth Enterprises LLC lifted its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 13.6% during the third quarter, according to its most recent disclosure with the ...

the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011. Passively managed ETFs are becoming increasingly popular with institutional as well as retail ...

Chicago Partners Investment Group LLC grew its position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 45.8% during the third quarter, according to the company in its most recent 13F ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Bionomics shares are trading higher by 104% Tuesday morning. The company announced a AUD$1 million milestone payment from ...